Vis enkel innførsel

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

dc.contributor.authorBjørk, Marte-Helene
dc.contributor.authorZoega, Helga
dc.contributor.authorLeinonen, Maarit K.
dc.contributor.authorCohen, Jacqueline Mallory
dc.contributor.authorDreier, Julie Werenberg
dc.contributor.authorFuru, Kari
dc.contributor.authorGilhus, Nils Erik
dc.contributor.authorGissler, Mika
dc.contributor.authorHalfdanarson, Oskar
dc.contributor.authorIgland, Jannicke
dc.contributor.authorSun, Yuelian
dc.contributor.authorTomson, Torbjörn
dc.contributor.authorAlvestad, Silje
dc.contributor.authorChristensen, Jakob
dc.date.accessioned2022-09-19T07:35:38Z
dc.date.available2022-09-19T07:35:38Z
dc.date.created2022-07-15T15:54:31Z
dc.date.issued2022
dc.identifier.citationJAMA Neurology. 2022, 79 (7), 672-681.
dc.identifier.issn2168-6149
dc.identifier.urihttps://hdl.handle.net/11250/3018689
dc.language.isoeng
dc.titleAssociation of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
dc.title.alternativeAssociation of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber672-681
dc.source.volume79
dc.source.journalJAMA Neurology
dc.source.issue7
dc.identifier.doi10.1001/jamaneurol.2022.1269
dc.identifier.cristin2038473
dc.relation.projectNorges forskningsråd: 273366
dc.relation.projectNordforsk: 83796
dc.relation.projectNorges forskningsråd: 262700
dc.relation.projectNordforsk: 83539
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Filnavn:
jamaneurology_bjrk_2022_oi_220 ...
Størrelse:
393.1Kb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel